(WASHINGTON) — U.S. scientists would gain vastly expanded capabilities to identify potentially deadlier coronavirus mutations under legislation advancing in Congress. A House bill headed for floor debate would provide $1.75 billion for genomic sequencing. The U.S. now maps only the genetic makeup of a minuscule fraction of positive virus samples, a situation some experts liken to flying blind.